학술논문
988P Safety analysis of the run-in phase (1st and 2nd cohort) of the IMMUNIB trial (AIO-HEP-0218/ass) - An open-label, single-arm phase II study evaluating safety and efficacy of immunotherapy with nivolumab in combination with lenvatinib in advanced stage HCC
Document Type
Abstract
Author
Source
In Annals of Oncology September 2020 31 Supplement 4:S691-S691
Subject
Language
ISSN
0923-7534